Partner with Xentria Inc. for Unmatched Growth

Xentria, Inc. 224-443-4615 [email protected]. Brief Summary: A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis. Read more. Recent Posts ... Location: Xentria Investigative Site. City/State: Greenville, North ... Xentria, Inc. 224-443-4615 [email protected]. Brief Summary: A phase 1b/2 ... Xellia is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Ensayos clínicos para Xentria, Inc.. Registro de ensayos clínicos. ICH GCP. CHICAGO, Dec. 19, 2024 /PRNewswire/ -- Xentria, Inc. (Xentria), a clinical-stage biotherapeutics company focused on advancing drug development ... ... companies. To access further details of the event and to register at no cost ... VP & Head of Clinical. Development roles at Xentria,. Inc. A randomized, double-blind, parallel-group, active-controlled study to compare the efficacy, pharmacokinetics, pharmacodynamics, safety, and immunogenicity of ... Xentria, Inc. Pulmonary Sarcoidosis. 04/26. 04/26. Stavropoulos, Ioannis. CENOR, NCT05747001: This is a Retrospective Study on the Use of CENOBAMATE as ... Trademark registration by Xentria, Inc. for the trademark XENTRIA. Xentria is a pioneering biopharmaceutical company focused on developing biologic and innovative drug therapies. Their investigational drug, XTMAB-16, is a ...